Showing 11,641 - 11,660 results of 33,375 for search '"authority"', query time: 0.10s Refine Results
  1. 11641
  2. 11642
  3. 11643
  4. 11644
  5. 11645
  6. 11646
  7. 11647
  8. 11648
  9. 11649
  10. 11650
  11. 11651
  12. 11652
  13. 11653
  14. 11654
  15. 11655
  16. 11656
  17. 11657
  18. 11658
  19. 11659

    Safety and efficacy of the amino acid-crosslinked hyaluronic acid in the treatment of temple hollowing by Yanping Guo, Puzhen Li, Wuhan Wei, Qiang Li, Caiqi Shen, Xiaoying Zhuo, Yujie Luo, Jie Liu, Peisheng Jin, Xueyang Li

    Published 2025-02-01
    “…Background: Loss of volume in the temples is an early sign of aging and often gives the impression of a gaunt and emaciated appearance. Objective: The authors conduct a clinical study to investigate the safety and effectiveness of the amino acid crosslinked hyaluronic acid (ACHA) for the treatment of temple hollowing. …”
    Get full text
    Article
  20. 11660

    Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024 by Yamin Shu, Wenxin Cheng, Xucheng He, Liu Huang, Wei Chen, Qilin Zhang

    Published 2025-02-01
    “…Background: Recombinant zoster vaccine (RZV), received its first marketing authorization in October 2017 to prevent herpes zoster and its complications in older adults. …”
    Get full text
    Article